1029 studies found for:    Open Studies | "Connective Tissue Diseases"
Show Display Options
Rank Status Study
21 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
22 Recruiting Biomarker for Maroteaux-Lamy Disease
Conditions: Maroteaux-lamy Disease;   Lysosomal Storage Diseases
Intervention:
23 Recruiting Biomarker for Morquio Disease
Conditions: Lysosomal Storage Diseases;   Morquio Disease
Intervention:
24 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
25 Unknown  Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
26 Unknown  Ultraviolet Light Therapy for Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: ultraviolet A-1 light treatment
27 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
28 Recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
29 Recruiting Relationship Between the Activity of Rheumatoid Arthritis and Lymph Node Morphology and Lymphatics Drainage
Conditions: Rheumatoid Arthritis;   Lymph Node Mass;   Lymphatic Vessel; Dilatation
Intervention: Drug: indocyanine green(ICG)
30 Not yet recruiting Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Ticagrelor;   Drug: MTX therapy
31 Recruiting Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
Condition: Rheumatoid Arthritis
Interventions: Drug: Filgotinib;   Drug: Placebo to match filgotinib;   Drug: csDMARDs
32 Recruiting Preventive Fixation of Lower Limbs in Osteogenesis Imperfecta (Brittle Bone Disease) With the Highlight of the Fassier-Duval
Condition: Brittle Bone Disease
Intervention: Device: Fassier-Duval Nail
33 Recruiting A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: ASP1707;   Drug: methotrexate (MTX)
34 Not yet recruiting SCLERoderma et Adipose-DErived Stroma Cells
Condition: Systemic Sclerosis
Interventions: Drug: Stromal Vascular fraction;   Drug: Ringer lactate
35 Not yet recruiting An Evaluation of the Safety of Escalating Doses of Tc 99m Tilmanocept by Intravenous (IV) Injection and Skeletal Joint Imaging With SPECT in Subjects With Active Rheumatoid Arthritis (RA) and Healthy Controls
Condition: Arthritis, Rheumatoid
Interventions: Drug: Tc99m tilmanocept;   Procedure: 30 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest;   Procedure: 90 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest;   Procedure: 180 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest
36 Not yet recruiting Hospitalization at Home: The Acute Care Home Hospital Program for Adults
Conditions: Pneumonia;   Heart Failure;   Cellulitis;   Urinary Tract Infections
Interventions: Other: Home hospitalization;   Other: Inpatient Hospitalization
37 Recruiting Optic Neuritis and Ganglion Cell Layer
Condition: Optic Neuritis
Intervention:
38 Not yet recruiting GS-5745 as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: GS-5745;   Drug: Placebo;   Drug: Methotrexate;   Drug: TNF Inhibitor
39 Not yet recruiting Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Condition: Arthritis, Rheumatoid
Interventions: Drug: GSK2982772 60 mg;   Drug: Placebo
40 Recruiting Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease
Condition: Horton's Disease
Intervention: Biological: Blood samples

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years